Skip to main content
Clinical Trials/DRKS00022891
DRKS00022891
Completed
Not Applicable

Observational study on the efficacy of multimodal complex therapy and Viscum album extract in the treatment of patients with advanced lung cancer - ACCEPT-1

Forschungsinstitut Havelhöhe gGmbH0 sites101 target enrollmentAugust 19, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C34
Sponsor
Forschungsinstitut Havelhöhe gGmbH
Enrollment
101
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 19, 2020
End Date
December 15, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Expected three months participation in ACCEPT possible
  • German language
  • Once a week in hospital Participation in the education program

Exclusion Criteria

  • No German language
  • Expected to last less than three months
  • Mobility to weekly therapy not given

Outcomes

Primary Outcomes

Not specified

Similar Trials